4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-026604
Chief Financial Officer sold 9,200 shares at $23.00 ($211,614)
- Chief Financial Officer acquired 9,200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hyep Ivan Chief Financial Officer | 2026-04-21 | Option exercise 10b5-1 | +9,200 | $3.79 | $34,866 | 154,555 | D |
| Hyep Ivan Chief Financial Officer | 2026-04-21 | Sale 10b5-1 | −9,200 | $23.00 | $211,614 | 145,355 | D |
| Derivatives | |||||||
| Hyep Ivan Chief Financial Officer | 2026-04-21 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,200 | 39,744 | D | ||
| Open-market sales · 9,200 sh · avg $23.00 · $211,614 | |||||||
Loading xslF345X06/wk-form4_1776891211.xml…